Switzerland gives green light to new Roche cancer treatment
117223
The Swiss drug giant Roche said it had won approval in Switzerland for a new cancer drug Avastin and hoped to get the go-ahead in over 90 other countries, including the European Union, soon.
352683
Swiss voters approved measures to allow scientists to take stem cells from unwanted embryos to be used for research into diseases.
682887
A new treatment developed at Newcastle University uses light-sensitive antibodies that allow doctors to target tumours with precision, leaving healthy tissues untouched.
692230
Genentech Inc. and Swiss drug maker Roche Holding AG said Monday that a recent study showed their colon cancer drug Avastin significantly extended patient survival when combined with oxaliplatin-based chemotherapy drugs.
746039
Data showed that Roche Holding AG's Xeloda was as effective in adjuvant treatment of Dukes' C colon cancer as the current standard treatment, the Swiss pharmaceutical company said on Tuesday.
581540
A new needle-free way is developed to deliver treatment to skin cancer patients, researchers say.
140958
A major trial of one of a new generation of "smart" drugs that selectively attacks cancer cells is launched.
758098
German drugmaker Schering AG said on  Thursday that the U.S. Food and Drug Administration had granted  its breast cancer treatment bonefos "priority review" status.
690168
LONDON -- GlaxoSmithKline PLC, the world's second-largest pharmaceutical company, said Monday that it expects to introduce five new cancer treatments through 2010.
254957
Scientists have identified a way of tackling hard-to-treat breast cancers.
626896
Mixing cells and eggs to be allowed in search for new medical treatments.
15160
The Swiss pharmaceutical company Roche Holding said its chief executive would step down next March as the company separates that job from the chairmanâs position. Franz B. Humer, who has been chief since 1998, will remain chairman of the board. Next July, he also will become chairman of the beverage company Diageo. He will be succeeded by Severin Schwan, 40, who had been the head of Rocheâs diagnostics unit since January. The company also posted a 24 percent increase in first-half net profit, to 4.92 billion Swiss francs ($4.1 billion) from 3.97 billion francs in the period a year earlier. Roche benefited from its flu treatment Tamiflu as governments stockpile the drug in case of an influenza pandemic.
283402
BASEL, Switzerland  - Profits at Roche Holding AG leapt 34 percent in 2006 on strong sales of cancer treatments Herceptin and Avastin and flu drug Tamiflu but worries over future margins hit the stock on Wednesday.
302408
Swiss drugmaker Roche beat forecasts  with a 37 percent rise in first-half net income to 4.543  billion Swiss francs ($3.62 billion), boosted by bumper growth  in its cancer drugs.
400507
GENEVA  - Two-thirds of Swiss voters approved a new law that allows medical research on stem cells taken from human embryos but bars cloning, official results from a referendum showed.
740075
New clinical data showed Avastin  improved the chances of a removal of metastatic lesions in  patients with colorectal cancer, Swiss drugmaker Roche Holding  AG said on Monday.
578661
Basel, Switzerland, November 30 (ots/PRNewswire) - Roche and Genentech, Inc., announced today that Avastin(TM) (bevacizumab, rhuMAb-VEGF), a new innovative anti-angiogenesis drug, has shown for the first time that it significantly increases survival in